Skip to Main Content

Author Details

Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
2002
33
21
PMIDPaper TitleJournal TitlePublished Year
35308924Parsing Immune Correlates of Protection Against SARS-CoV-2 from Biomedical Literature.AMIA Annu Symp Proc2022
35308924Parsing Immune Correlates of Protection Against SARS-CoV-2 from Biomedical Literature.AMIA Annu Symp Proc2022
37645170Radical collaboration during a global health emergency: development of the RDA COVID-19 data sharing recommendations and guidelines.Open Res Eur2021
37645170Radical collaboration during a global health emergency: development of the RDA COVID-19 data sharing recommendations and guidelines.Open Res Eur2021
29346583DataMed - an open source discovery index for finding biomedical datasets.J Am Med Inform Assoc2018
29346583DataMed - an open source discovery index for finding biomedical datasets.J Am Med Inform Assoc2018
29202203User needs analysis and usability assessment of DataMed - a biomedical data discovery index.J Am Med Inform Assoc2018
29202203User needs analysis and usability assessment of DataMed - a biomedical data discovery index.J Am Med Inform Assoc2018
28546571Finding useful data across multiple biomedical data repositories using DataMed.Nat Genet2017
28546571Finding useful data across multiple biomedical data repositories using DataMed.Nat Genet2017
28585923DATS, the data tag suite to enable discoverability of datasets.Sci Data2017
29220453A publicly available benchmark for biomedical dataset retrieval: the reference standard for the 2016 bioCADDIE dataset retrieval challenge.Database (Oxford)2017
29220453A publicly available benchmark for biomedical dataset retrieval: the reference standard for the 2016 bioCADDIE dataset retrieval challenge.Database (Oxford)2017
28585923DATS, the data tag suite to enable discoverability of datasets.Sci Data2017
26861698Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.J Transl Med2016
26861698Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.J Transl Med2016
25795775A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.J Biol Chem2015
25795775A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.J Biol Chem2015
26210361Ease of adoption of clinical natural language processing software: An evaluation of five systems.J Biomed Inform2015
26210361Ease of adoption of clinical natural language processing software: An evaluation of five systems.J Biomed Inform2015
22729867Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.Int J Cancer2013
22729867Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.Int J Cancer2013
23359207Regulation of HGF expression by οEGFR-mediated c-Met activation in glioblastoma cells.Neoplasia2013
23250739Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of οEGFR/EGFRvIII.J Biol Chem2013
23250739Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of οEGFR/EGFRvIII.J Biol Chem2013
23359207Regulation of HGF expression by οEGFR-mediated c-Met activation in glioblastoma cells.Neoplasia2013
20651739Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator.EMBO Rep2010
21104971Inhibition of ascites tumor growth in vivo by sTie-2 is potentiated by a combinatorial therapy with sFLT-1.J Gene Med2010
20651739Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator.EMBO Rep2010
21104971Inhibition of ascites tumor growth in vivo by sTie-2 is potentiated by a combinatorial therapy with sFLT-1.J Gene Med2010
19266483Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.J Gene Med2009
19266483Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.J Gene Med2009
17505058Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).Mol Endocrinol2007
17505058Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).Mol Endocrinol2007
17671180Identification of Pax5 as a target of MTA1 in B-cell lymphomas.Cancer Res2007
17671172Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.Cancer Res2007
17389360Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1.Proc Natl Acad Sci U S A2007
17671180Identification of Pax5 as a target of MTA1 in B-cell lymphomas.Cancer Res2007
17671172Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.Cancer Res2007
17389360Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1.Proc Natl Acad Sci U S A2007
16617102MTA1, a transcriptional activator of breast cancer amplified sequence 3.Proc Natl Acad Sci U S A2006
165746519-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.J Biol Chem2006
16467116Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.Clin Cancer Res2006
16855396Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer.Cell Cycle2006
16617102MTA1, a transcriptional activator of breast cancer amplified sequence 3.Proc Natl Acad Sci U S A2006
16723992p21-activated kinases in cancer.Nat Rev Cancer2006
16723992p21-activated kinases in cancer.Nat Rev Cancer2006
16855396Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer.Cell Cycle2006
16467116Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.Clin Cancer Res2006
165746519-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.J Biol Chem2006
  • 1 - 50 of 66

Recommended Authors

International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 6
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 0
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
University of Toronto
Career Start Year 1990
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 1
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 4
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 5
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 8
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 0
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 0
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 1
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 4
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 19

Collaborators

Rutgers New Jersey Medical School
Co-authored papers 16
Yale University
Co-authored papers 6
Co-authored papers 5
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 5
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 5
University of Michigan ann arbor
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Oxford e-Research Centre, University of Oxford
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas Health Science Center at Houston
Co-authored papers 3
The College of Nursing, Seoul National University
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
University of Oxford
Co-authored papers 3
Oxford e-Research Centre, University of Oxford
Co-authored papers 3
university of california san diego
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
The University of Texas Health Science Center at Houston
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Center for Research in Biological Systems.
Co-authored papers 2
SciCrunch Inc.
Co-authored papers 2
Moffitt Cancer Center
Co-authored papers 2
The University of Texas Health Science Center at Houston
Co-authored papers 2
University of Texas Health Science Center at Houston
Co-authored papers 2
The University of Texas Health Science Center at Houston
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Washington (A.M.U., University of Washington (J.S.
Co-authored papers 2
Industrial Technology Research Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1